Novo Nordisk A/S
Methods for treating IL-6 mediated inflammation without immunosuppression

Abstract:

The disclosure provides methods of treating inflammation without inducing immune suppression. The method comprises administering a therapeutically effective amount of an IL-6 antagonist at a dose sufficient to reduce inflammation without causing immune suppression.